ArticleHealth science reports2026
Respiratory Viral Co-Infections in SARS-CoV-2 Positive Patients in Burkina Faso: A Cross-Sectional Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The burden of viral co-infections among COVID-19 patients is underexplored in low-resource settings such as Burkina Faso. This study aimed to determine the prevalence and associated factors of respiratory viral co-infections among laboratory-confirmed COVID-19 patients. Methods: A cross-sectional study was conducted from January 1 to December 31, 2023, across 13 sentinel sites in Burkina Faso. Patients presenting with influenza-like illness or severe acute respiratory infection had nasopharyngeal and/or oropharyngeal swabs collected and tested for SARS-CoV-2 and other respiratory viruses using multiplex real-time RT-PCR. Descriptive statistics, univariate, and multivariate logistic regression analyses were performed to identify predictors of viral co-infections. Results: Among 201 SARS-CoV-2-positive patients enrolled (median age: 1 year; interquartile range: 0.5-7). Co-infections was identified in 48.8% (95% CI: 41.8-55.6) of cases and a single co-infections was detected in 33.8% (95% CI: 27.5-40.6) of patients. Human rhinovirus (17.9%), adenovirus (14.4%), respiratory syncytial virus (11.4%), and influenza A/B (9.9%) were most frequently detected. In multivariate analysis, children aged 6 months to 14 years had higher odds of co-infection (aOR 2.7; 95% CI: 1.2-5.9; Conclusion: Viral co-infections were frequent among SARS-CoV-2 positive patients, particularly in children and hospitalized individuals. Strengthening multiplex diagnostic capacity and integrated respiratory virus surveillance in resource-limited settings may improve clinical management and inform public health response strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.